Johnson USA AIDS-related Intravenous Route of 3 health states: Patients TTO (1996) ganciclovir administration patients current s retinitis compared (intravenous vs. state of health; IV treatment with oral oral) therapy: oral ganciclovir therapy Kauf HIV treatment Treatment Dose frequency, No, SF-36 in HIV Patients SF-6D (2008) patients regimen symmetrical attributes (Europe regimen, and the treatment taken USA) with food/drink/empty stomach Matza UK Bone Intravenous Hypothetical General VAS and TTO (2013) metastasis (infusion) health states: population (with renal bone metastases; monitoring) plus 9 additional
Johnson (1996) USA AIDS-related retinitis treatment Intravenous ganciclovir compared with oral ganciclovir Route of administration (intravenous vs. oral) 3 health states: patients current state of health; IV therapy: oral therapy Patients TTO Kauf (2008) (Europe and the USA) HIV treatment Treatment regimen attributes Dose frequency, symmetrical regimen, treatment taken with food/drink/empty stomach No, SF-36 in HIV patients Patients SF-6D Matza (2013) UK Bone metastasis Intravenous (infusion) (with renal monitoring) Hypothetical health states: bone metastases; plus 9 additional General population VAS and TTO s
VKBrennan%20THESIS%20FINAL%20%28including%20appendix%29.docx